First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
Launched by NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS · Apr 20, 2025
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new way to diagnose pleural effusion, which is a buildup of fluid in the space around the lungs. The study specifically looks at patients who may have cancer-related fluid in this area. It compares a new method called Local Anesthesia Thoracoscopy (LAT) with standard diagnostic methods. LAT allows doctors to take a tissue sample directly from the pleural space while the patient is awake and comfortable. The trial aims to see how well this new method works, how quickly it helps make a diagnosis, and how safe and comfortable it is for patients.
To participate in the trial, patients must be between the ages of 65 and 74 and have an undiagnosed pleural effusion that has certain characteristics. However, some patients may not be eligible if they have certain conditions, like infections in the pleural space or severe breathing difficulties. If someone joins the trial, they can expect to undergo the LAT procedure and be closely monitored for its effectiveness and their comfort during the process. This research could help improve how doctors diagnose and treat pleural effusion in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undiagnosed pleural effusion with the character of a lymphocytic exudate
- Exclusion Criteria:
- • Empyema
- • Transudate pleural effusion.
- • Central airway obstruction by tumor.
- • Existence of extensive adhesions that do not allow the development of iatrogenic pneumothorax and the safe entry of the thoracoscope.
- • Uncontrollable cough.
- • Acute respiratory failure and/or Hypercapnia.
- • Performance Status: 5
About National And Kapodistrian University Of Athens
The National and Kapodistrian University of Athens is a prestigious academic institution in Greece, renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials aimed at improving healthcare outcomes. Its dedicated research teams leverage cutting-edge methodologies and a diverse range of expertise to address critical health challenges. As a clinical trial sponsor, the university prioritizes ethical standards and the welfare of participants, contributing significantly to the global body of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Attica, Greece
Patients applied
Trial Officials
Grigorios Stratakos, Professor
Study Director
National and Kapodistrian University of Athens
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported